Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients

Psychological Medicine

Volumn 26, Issue 4, 1996, Pages 669-679

  Johnstone, Eve C ^a   Frith, Christopher D ^b  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; COGNITION; DELUSION; DEMOGRAPHY; DISORIENTATION; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOM;

EID: 0030016169     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0033291700037685     Document Type: Article

References (47)

1. Ammons, R. B. & Ammons, C. H. (1962). The Quick Test: provisional manual. Psychological Reports 11, 111-161.
2. Andreasen, N. C. & Olsen, S. (1982). Negative v. positive schizophrenia: definition and validation. Archives of General Psychiatry 39, 789-794.
3. Angrist, B., Rotrosen, J. & Gershon S. (1980). Differential effects of amphetamine and neuroleptics on negative vs positive symptoms of schizophrenia. Psychopharmacology 72, 17-19.
4. Arndt, S., Alliger, R. J. & Andreasen, N. C. (1991). The destruction of positive and negative symptoms: the failure of a two dimensional model. British Journal of Psychiatry 58, 317-322.
5. Bech, P., Rafaelsen, O. J., Kramp, P. & Bolwig, T. (1978). The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 17, 430-431.
6. Bench, C. J., Dolan, R. J., Friston, K. J. & Frackowiak, R. S. J. (1990). Positron Emission Tomography in the study of brain metabolism in psychiatric and neuropsychiatric disorders. British Journal of Psychiatry 157 (suppl. 9), 82-95.
7. Bilder, R. M., Mukherjee, S., Reider, R. O. & Pandurangi, A. K. (1985). Symptomatic and neuropsychological components of defect states. Schizophrenia Bulletin 11, 409-419.
8. Carpenter, W. T., Heinrichs, D. W. & Wagman, A. M. I. (1988). Deficit and non-deficit forms of schizophrenia: the concept. American Journal of Psychiatry 145, 578-583.
9. Crow, T. J. (1980). Molecular pathology of schizophrenia: more than one disease process. British Medical Journal 280, 66-68.
10. Falloon, I. R. H. & Talbot, R. E. (1981). Persistent auditory hallucinations: coping mechanisms and implications for management. Psychological Medicine 11, 329-339.
11. Feighner, J. P., Robins E., Guze S., Woodruff, R., Winokur, A. & Munoz, R (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 57-62.
12. Fenton W. S. & McGlashan T. H. (1991). Natural history of schizophrenia subtypes. 1. longitudinal study of paranoid, hebephrenic and undifferentiated schizophrenia. Archives of General Psychiatry 48, 969-977.
13. Fish F. (1962). Schizophrenia. Wright: Bristol.
14. Frith, C. D, Leary, J., Cahill, C. & Johnstone E. C. (1991). Disabilities and circumstances of schizophrenic patients - a follow-up study. IV. Performance on psychological tests. British Journal of Psychiatry 159 (suppl. B), 26-29.
15. Garmezy, N. (1978). Attentional process in adult schizophrenia and children at risk. Journal of Psychiatric Research 14, 3-34.
16. Guy, W. (1976). ECDEU Manual for Psychopharmacology, pp. 534-537. DHEW: Washington DC.
17. Hirsch, S. R. (1982). Depression 'revealed' in schizophrenia. British Journal of Psychiatry 140, 421-424.
18. Johnstone, E. C. (1989). The assessment of negative and positive features in schizophrenia. British Journal of Psychiatry 155 (suppl. 7), 41-44.
19. Johnstone, E. C. (1992). Heterogeneity in Schizophrenia. Clinical and Biological Aspects. In New Biological Vistas on Schizophrenia (ed. J. P. Lindenmeyer and S. R. Kay), pp. 110-128. Brunner-Mazel: New York.
20. Johnstone, E. C., Crow, T. J., Frith, C. D., Carney, M. W. P. & Price, J. S. (1978). Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet i, 848-851.
21. Johnstone, E. C., Owens, D. G. C., Frith, C. D. & Crow, T. J. (1987). The relative stability of positive and negative features in chronic schizophrenia. British Journal of Psychiatry 150, 60-64.
22. Johnstone, E. C., Frith, C. D., Leary, J., Owens, D. G. C., Wilkins, S. & Hershon, H.I. (1991). Disabilities and circumstances of schizophrenic patients - a follow-up study. I. background, method and general description of the sample. British Journal of Psychiatry 159 (suppl 13), 7-12.
23. Kay, S. R. & Singh, M. M. (1989). The positive-negative distinction in drug-free schizophrenic patients: stability, response to neuroleptics and prognostic significance. Archives of General Psychiatry 46, 711-718.
24. Kay, S. R., Fiszbein, A. & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
25. Kleist, K. (1947). Fortschrilk der Psychiatrie. A. M. Kramer: Frankfurt.
26. Kraepelin, E. (1896). Psychiatrie, Ein Lehrbuch fur Studierende und Artze (5th edn). Barth: Leipzig. Kraepelin, E. (1919). Dementia Praecox and Paraphrenia. Translated by R. M. Barclay. Reprinted in 1971 by R. E. Krieger: New York.
27. Kraepelin, E. (1896). Psychiatrie, Ein Lehrbuch fur Studierende und Artze (5th edn). Barth: Leipzig. Kraepelin, E. (1919). Dementia Praecox and Paraphrenia. Translated by R. M. Barclay. Reprinted in 1971 by R. E. Krieger: New York.
28. Krawiecka, M., Goldberg, D. & Vaughan, M. (1977). A standardised psychiatric assessment for rating psychotic patients. Acta Psychiatrica Scandinavica 55, 299-308.
29. Kulhara, P., Kota, S. K. & Joseph, S. (1986). Positive and negative subtypes of schizophrenia: a study from India. Acta Psychiatrica Scandinavica 74, 353-359.
30. Leonhard, K. (1960). Die Atypische Psychosen und Kleist's Lehre von Endogenen Psychosen. In Psychiatrie der Gegenwart, Vol. II (ed. H. W. Gruhle, R. Jung, W. Mayer-Gross and M. Muller), pp. 147-179. Springer: Berlin.
31. Liddle, P. F. (1987a). The symptoms of chronic schizophrenia: a reexamination of the positive-negative dichotomy. British Journal of Psychiatry 151, 145-151.
32. Liddle, P. F. (1987b). Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine 17, 49-57.
33. Liddle, P. F. & Morris, D. L. (1991). Schizophrenic syndromes and frontal lobe performance. British Journal of Psychiatry 158, 340-345.
34. Liddle, P. F., Friston, K. J., Hirsch, S. R. & Frackowiak, R. S. J. (1990). Regional cerebral metabolic activity in chronic schizophrenia. Schizophrenia Research 3, 23-24.
35. McGlashan, T. H. & Carpenter, W. T. (1976). Post-psychotic depression in schizophrenia. Archives of General Psychiatry 33, 231-239.
36. McKenna, P. J., Lund, C. E. & Mortimer, A. M. (1989). Negative symptoms: relationship to other schizophrenic symptoms classes. British Journal of Psychiatry 155 (suppl. 7), 104-107.
37. Mayer-Gross, W. (1920). Über die Stellungsnahme auf abgelanfenen akuten Psychose. Zeitschrift für Gesamte Neurologie und Psychiatrie 60, 160-212.
38. Montgomery, S. A. & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 157, 50-54.
39. Murray, R. M. & Lewis, S. W. (1987). Is schizophrenia a neuro-developmental disorder? British Medical Journal 295, 681-682.
40. Rifkin, A., Quitkin, F. & Klein, D. F. (1975). Akinesia. Archives of General Psychiatry 32, 672-674.
41. Shallice, T. (1988). From Neuropsychology to Mental Structure. Cambridge University Press: Cambridge.
42. Shallice, T., Burgess, P. & Frith, C. D. (1991). Can the neuropsychological case-study approach be applied to schizophrenia? Psychological Medicine 21, 661-673.
43. Sommers, A. A. (1985). 'Negative symptoms', conceptual and methodological problems. Schizophrenia Bulletin 11, 364-378.
44. Strauss, J. S., Carpenter, W. T. & Bartko, J. P. (1974). The diagnosis and understanding of schizophrenia. III. Speculation on the process that underlie schizophrenic symptoms and signs. Schizophrenia Bulletin 1, 61-76.
45. Van der Does, A. J. W., Dingemans, P. M. A. J., Linszen, D. H., Nugter, M. A. & Scholte, W. T. (1993). Symptom dimensions and cognitive and social functioning in recent onset schizophrenia. Psychological Medicine 23, 745-753.
46. Wojcik, J. D., Gelenberg, A. G., Labrie, R. A. & Mieske, M. (1980). Prevalence of tardive dyskinesia in an out-patient population. Comprehensive Psychiatry 21, 370-380.
47. World Health Organization (1978). Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. WHO: Geneva.